Literature DB >> 28247010

Pathological and molecular analyses of atherosclerotic lesions in ApoE-knockout mice.

Masa-Aki Shibata1, Eiko Shibata2, Kentaro Maemura3, Yoichi Kondo3, Mariko Harada-Shiba2.   

Abstract

The establishment of consistent and reliable methods for the analysis of atherosclerosis molecular pathways and for testing the efficiency of new therapeutics is of utmost importance. Here, we fed ApoE-knockout (KO) mice with high-fat diet to for 16 weeks to induce atherosclerosis. Atherosclerotic lesions in mice were methodically investigated using pathologic analyses and molecular biology tools. These lesions were histopathologically classified into three categories: early, progressive, and combined lesions. Immunohistochemical analyses showed that both F4/80 (macrophage marker) and tenascin-C are expressed in these lesions. Real-time PCR analysis conducted using formalin-fixed paraffin-embedded tissues with atherosclerotic lesions demonstrated an increase in the levels of many inflammatory chemokines, including Cxcl16, while antibody arrays performed using frozen atherosclerotic tissue samples showed elevated TIMP-1 expression. Subsequent immunohistochemical analyses showed that the expression of CXCL16, TIMP-1, MMP-9, MMP-8, and LOX-1 is localized in the atherosclerotic lesions. We confirmed that the expression of these proteins is localized to atherosclerotic lesion, which suggests their roles in the development of the lesions in ApoE-KO mice. Therefore, this mouse model represents an appropriate tool for elucidating molecular mechanisms underlying the development of atherosclerosis, and a model for the evaluation of therapeutic efficiency of novel drugs.

Entities:  

Keywords:  Antibody array; ApoE-knockout mouse; Atherosclerosis; Pathology; Real-time PCR

Mesh:

Substances:

Year:  2017        PMID: 28247010     DOI: 10.1007/s00795-017-0154-y

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  49 in total

1.  A hypothesis for vulnerable plaque rupture due to stress-induced debonding around cellular microcalcifications in thin fibrous caps.

Authors:  Yuliya Vengrenyuk; Stéphane Carlier; Savvas Xanthos; Luis Cardoso; Peter Ganatos; Renu Virmani; Shmuel Einav; Lane Gilchrist; Sheldon Weinbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

2.  Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice.

Authors:  Kazuhiko Inoue; Yuji Arai; Hiroki Kurihara; Toru Kita; Tatsuya Sawamura
Journal:  Circ Res       Date:  2005-06-16       Impact factor: 17.367

Review 3.  Carotid artery stenting.

Authors:  Christopher J White
Journal:  J Am Coll Cardiol       Date:  2014-08-19       Impact factor: 24.094

4.  Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.

Authors:  I M Loftus; A R Naylor; S Goodall; M Crowther; L Jones; P R Bell; M M Thompson
Journal:  Stroke       Date:  2000-01       Impact factor: 7.914

5.  Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.

Authors:  Ara M Aslanian; Israel F Charo
Journal:  Circulation       Date:  2006-07-31       Impact factor: 29.690

6.  Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque.

Authors:  K Wallner; C Li; P K Shah; M C Fishbein; J S Forrester; S Kaul; B G Sharifi
Journal:  Circulation       Date:  1999-03-16       Impact factor: 29.690

Review 7.  A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice.

Authors:  Raymond Coleman; Tony Hayek; Shlomo Keidar; Michael Aviram
Journal:  Acta Histochem       Date:  2006-09-26       Impact factor: 2.479

8.  Peptide-retargeted adenovirus encoding a tissue inhibitor of metalloproteinase-1 decreases restenosis after intravascular gene transfer.

Authors:  Mikko P Turunen; Hanna L Puhakka; Jonna K Koponen; Mikko O Hiltunen; Juha Rutanen; Olli Leppänen; Anna-Mari Turunen; Ale Närvänen; Andrew C Newby; Andrew H Baker; Seppo Ylä-Herttuala
Journal:  Mol Ther       Date:  2002-09       Impact factor: 11.454

9.  Guidelines for the management of familial hypercholesterolemia.

Authors:  Mariko Harada-Shiba; Hidenori Arai; Shinichi Oikawa; Takao Ohta; Tomoo Okada; Tomonori Okamura; Atsushi Nohara; Hideaki Bujo; Koutaro Yokote; Akihiko Wakatsuki; Shun Ishibashi; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2012-10-25       Impact factor: 4.928

10.  Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice.

Authors:  Tsuyoshi Yamamoto; Mariko Harada-Shiba; Moeka Nakatani; Shunsuke Wada; Hidenori Yasuhara; Keisuke Narukawa; Kiyomi Sasaki; Masa-Aki Shibata; Hidetaka Torigoe; Tetsuji Yamaoka; Takeshi Imanishi; Satoshi Obika
Journal:  Mol Ther Nucleic Acids       Date:  2012-05-15       Impact factor: 10.183

View more
  4 in total

1.  Bacteroides fragilis Supplementation Deteriorated Metabolic Dysfunction, Inflammation, and Aorta Atherosclerosis by Inducing Gut Microbiota Dysbiosis in Animal Model.

Authors:  Guoxiang Shi; Yubi Lin; Yuanyuan Wu; Jing Zhou; Lixiang Cao; Jiyan Chen; Yong Li; Ning Tan; Shilong Zhong
Journal:  Nutrients       Date:  2022-05-25       Impact factor: 6.706

2.  PM2.5 inhalation induces intracranial atherosclerosis which may be ameliorated by omega 3 fatty acids.

Authors:  Longfei Guan; Xiaokun Geng; Jiamei Shen; James Yip; Fengwu Li; Huishan Du; Zhili Ji; Yuchuan Ding
Journal:  Oncotarget       Date:  2017-12-16

3.  Coenzyme Q10 protects against hyperlipidemia-induced cardiac damage in apolipoprotein E-deficient mice.

Authors:  Xiaoqing Zhang; Hongyang Liu; Yuhua Hao; Lulu Xu; Tiemei Zhang; Yingshu Liu; Lipeng Guo; Liyue Zhu; Zuowei Pei
Journal:  Lipids Health Dis       Date:  2018-12-08       Impact factor: 3.876

Review 4.  Autoimmune Rheumatic Diseases: An Update on the Role of Atherogenic Electronegative LDL and Potential Therapeutic Strategies.

Authors:  Der-Yuan Chen; Tatsuya Sawamura; Richard A F Dixon; José Luis Sánchez-Quesada; Chu-Huang Chen
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.